Lineage Cell Therapeutics, Inc. Grants Receivable
Lineage Cell Therapeutics, Inc. (LCTX) had Grants Receivable of $3.80 million as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Nontrade Receivables
us-gaap:GrantsReceivable · last filed 2016-03-15
- 2015-12-31: Grants Receivable $3.80M.
- 2014-12-31: Grants Receivable $2.60M; Grants Receivable as first filed $2.64M.
- 2013-12-31: Grants Receivable $1.35M.
- 2012-12-31: Grants Receivable $392.66K.
| Period end | Grants Receivable | Grants Receivable as first filed |
|---|---|---|
| 2015-12-31 | $3.80M 10-K · filed 2016-03-15 | |
| 2014-12-31 | $2.60M 10-K · filed 2016-03-15 | $2.64M 10-K · filed 2015-03-11 |
| 2013-12-31 | $1.35M 10-K · filed 2015-03-11 | |
| 2012-12-31 | $392.66K 10-K · filed 2013-03-18 | |
| 2009-04-29 | $4.72M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |